
16 Feb Cellaion
Posted at 18:02h
in
Etienne Sokal, M.D., Ph.D., CEO
April 21 | 2:15pm | Gaudi 2 Ballroom
Mont-Saint-Guibert, Belgium
(Private)
In-Person Presentation
Cellaïon is a new company created in 2021, using cell signaling technology to treat life threatening liver diseases. The company is currently in phase IIB clinical development, actively recruiting, in Acute on Chronic Liver Failure.